608 participants
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-18
- Start Date:
- 2021-12-31
- Completion:
- 2025-11-30
Conditions
- TTN
- Respiratory Failure
- PPHN
Interventions
- DRUG
No Results Yet